Angelica Loskog (A Loskog, A S I Loskog)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 11

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Top Venues

Cancer gene therapy

Journal of cellular and molecular medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Sedigheh Naseri, Mariela Mejia Cordova, Jessica Wenthe, Tanja Lövgren, Emma Eriksson, Angelica Loskog, Gustav J Ullenhag
CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling. Journal of cellular and molecular medicine 28 (7) (2024)
Sedigheh Naseri, Mariela Mejia Cordova, Jessica Wenthe, Tanja Lövgren, Emma Eriksson, Angelica Loskog, Gustav J Ullenhag
CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling. Journal of cellular and molecular medicine 28 (7) (2024)
Sedigheh Naseri, Mariela Mejia Cordova, Jessica Wenthe, Tanja Lövgren, Emma Eriksson, Angelica Loskog, Gustav J Ullenhag
CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling. Journal of cellular and molecular medicine 28 (7) (2024)
Tina Sarén, Mohanraj Ramachandran, Gustav Gammelgård, Tanja Lövgren, Claudio Mirabello, Åsa K Björklund, Kristina Wikström, Jamileh Hashemi, Eva Freyhult, Håkan Ahlström, Rose-Marie Amini, Hans Hagberg, Angelica Loskog, Gunilla Enblad, Magnus Essand
Single-cell RNA analysis reveals cell-intrinsic functions of CAR-T cells correlating with response in a phase II study of lymphoma patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jessica Wenthe, Sedigheh Naseri, Ann-Charlotte Hellström, Helena Jernberg Wiklund, Emma Eriksson, Angelica Loskog
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40. Cancer gene therapy 27 (12) (2020)
Sandra Irenaeus, Gustav J Ullenhag, Jessica Wenthe, Johan Krause, Anders Sundin, Håkan Ahlström, Gunnar Tufveson, Thomas H Tötterman, Angelica Loskog, Gustav J Ullenhag
Intratumoral immunostimulatory AdCD40L gene therapy in patients with advanced solid tumors. Cancer gene therapy 28 (10-11) (2020)
Eric K Rowinsky, Agne Paner, Jesus G Berdeja, Claudia Paba-Prada, Parameswaran Venugopal, Kimmo Porkka, Joachim Gullbo, Stig Linder, Angelica Loskog, Paul G Richardson, Ola Landgren
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma. Investigational new drugs 38 (5) (2020)
Emma Eriksson, Ioanna Milenova, Jessica Wenthe, Rafael Moreno, Ramon Alemany, Angelica Loskog
IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1. Journal of immunology (Baltimore, Md. : 1950) 202 (3) (2019)
Aglaia Schiza, Sandra Irenaeus, Francisco Ortiz-Nieto, Angelica Loskog, Thomas Tötterman, Anders Sundin, Gustav J Ullenhag, Håkan Ahlström
Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients. Scientific reports 9 (1) (2019)
Gunilla Enblad, Hannah Karlsson, Gustav Gammelgård, Jessica Wenthe, Tanja Lövgren, Rose-Marie Amini, Kristina I Wikstrom, Magnus Essand, Barbara Savoldo, Helene Hallböök, Martin Höglund, Gianpietro Dotti, Malcolm K Brenner, Hans Hagberg, Angelica Loskog
A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (24) (2018)
E Eriksson, R Moreno, I Milenova, L Liljenfeldt, L C Dieterich, L Christiansson, H Karlsson, G Ullenhag, S M Mangsbo, A Dimberg, R Alemany, Angelica Loskog
Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment. Gene therapy 24 (2) (2016)
L Liljenfeldt, L C Dieterich, A Dimberg, S M Mangsbo, Angelica Loskog
CD40L gene therapy tilts the myeloid cell profile and promotes infiltration of activated T lymphocytes. Cancer gene therapy 21 (3) (2014)